Ariadne Genomics, Inc. Technology Licensed by Takeda San Francisco For Evaluation of Potential Antibody Targets
Published: Jul 13, 2010
ROCKVILLE, MD— July 13, 2010 — Ariadne announces that Takeda San Francisco, Takeda’s global center for excellence for biologics, has signed an agreement to license Ariadne’s Pathway Studio® software. Takeda plans to utilize the software and underlying text-mining algorithms in their discovery program against cancer, inflammatory and metabolic diseases.
“We are pleased to add Takeda to our already distinguished list of clients”, says Gabriella Armin, Director of Marketing for Ariadne. “Our solutions for the pharmaceutical discovery pipeline are proven and we believe this research can enable the ongoing development of novel product candidates for therapeutic use.”
Ariadne (www.ariadnegenomics.com), a leader in research data products and knowledge enrichment- based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine. We provide a portfolio of solutions for life science, drug discovery and development applications including custom data products, knowledge extraction and visualization software, knowledge reports, and informatics staffing.
Pathway Studio, built and powered by MedScan® technology, is integrated data mining and visualization software that allows organizations and researchers to rapidly extract relevant facts and relationships from large document collections (text-mining), build focused knowledgebases (databases), while supporting the integration of OMICS experiments. The extracted knowledge is used in an interactive scaffold for defining and testing in silico-based hypotheses across a wide range of disciplines including mechanistic modeling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and many more.
Pathway Studio is available in desktop and enterprise versions along with therapeutic-focused knowledgebases and cartridges. For more information, visit us at www.ariadnegenomics.com.